153 related articles for article (PubMed ID: 24448063)
1. Synthesis of tetrahydrohonokiol derivates and their evaluation for cytotoxic activity against CCRF-CEM leukemia, U251 glioblastoma and HCT-116 colon cancer cells.
Bernaskova M; Kretschmer N; Schuehly W; Huefner A; Weis R; Bauer R
Molecules; 2014 Jan; 19(1):1223-37. PubMed ID: 24448063
[TBL] [Abstract][Full Text] [Related]
2. Semisynthesis and biological evaluation of novel honokiol thioethers against colon cancer cells HCT116 via inhibiting the transcription and expression of YAP protein.
Yang R; Fu X; Fan J; Wang T; Song J; Xu T; Guo Y; Zhang SY
Bioorg Med Chem; 2024 Jun; 107():117762. PubMed ID: 38759254
[TBL] [Abstract][Full Text] [Related]
3. Discovery and synthesis of novel magnolol derivatives with potent anticancer activity in non-small cell lung cancer.
Tang H; Zhang Y; Li D; Fu S; Tang M; Wan L; Chen K; Liu Z; Xue L; Peng A; Ye H; Chen L
Eur J Med Chem; 2018 Aug; 156():190-205. PubMed ID: 30006164
[TBL] [Abstract][Full Text] [Related]
4. Semi-synthesis and anti-proliferative activity evaluation of novel analogues of Honokiol.
Luo Y; Xu Y; Chen L; Hu J; Peng C; Xie D; Shi J; Huang W; Xu G; Peng M; Han J; Li R; Yang S; Wei Y
Bioorg Med Chem Lett; 2009 Aug; 19(16):4702-5. PubMed ID: 19589678
[TBL] [Abstract][Full Text] [Related]
5. Advances on Semisynthesis, Total Synthesis, and Structure-Activity Relationships of Honokiol and Magnolol Derivatives.
Yang C; Zhi X; Xu H
Mini Rev Med Chem; 2016; 16(5):404-26. PubMed ID: 26586125
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, Characterization and Biological Evaluation of Magnolol and Honokiol Derivatives with 1,3,5-Triazine of Metformin Cyclization.
Ren C; Wang J; Tan Y; Guo M; Guo J; Liu Y; Wu X; Feng Y
Molecules; 2020 Dec; 25(24):. PubMed ID: 33302335
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of magnolol and honokiol derivatives and their effect against hepatocarcinoma cells.
Maioli M; Basoli V; Carta P; Fabbri D; Dettori MA; Cruciani S; Serra PA; Delogu G
PLoS One; 2018; 13(2):e0192178. PubMed ID: 29415009
[TBL] [Abstract][Full Text] [Related]
8. Magnolol-induced apoptosis in HCT-116 colon cancer cells is associated with the AMP-activated protein kinase signaling pathway.
Park JB; Lee MS; Cha EY; Lee JS; Sul JY; Song IS; Kim JY
Biol Pharm Bull; 2012; 35(9):1614-20. PubMed ID: 22975518
[TBL] [Abstract][Full Text] [Related]
9. Biphenyl-type neolignans from stem bark of Magnolia officinalis with potential anti-tumor activity.
Ni HF; Cai X; Qiu X; Liu L; Ma X; Wan L; Ye H; Chen L
Fitoterapia; 2020 Nov; 147():104769. PubMed ID: 33152462
[TBL] [Abstract][Full Text] [Related]
10. Structural modification of honokiol, a biphenyl occurring in Magnolia officinalis: the evaluation of honokiol analogues as inhibitors of angiogenesis and for their cytotoxicity and structure-activity relationship.
Ma L; Chen J; Wang X; Liang X; Luo Y; Zhu W; Wang T; Peng M; Li S; Jie S; Peng A; Wei Y; Chen L
J Med Chem; 2011 Oct; 54(19):6469-81. PubMed ID: 21853991
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity of the bisphenolic honokiol from Magnolia officinalis against multiple drug-resistant tumor cells as determined by pharmacogenomics and molecular docking.
Saeed M; Kuete V; Kadioglu O; Börtzler J; Khalid H; Greten HJ; Efferth T
Phytomedicine; 2014 Oct; 21(12):1525-33. PubMed ID: 25442261
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of Bisphenol Neolignans Inspired by Honokiol as Antiproliferative Agents.
Cardullo N; Barresi V; Muccilli V; Spampinato G; D'Amico M; Condorelli DF; Tringali C
Molecules; 2020 Feb; 25(3):. PubMed ID: 32046220
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic compounds from the fruits of Uapaca togoensis towards multifactorial drug-resistant cancer cells.
Kuete V; Sandjo LP; Seukep JA; Zeino M; Mbaveng AT; Ngadjui B; Efferth T
Planta Med; 2015 Jan; 81(1):32-8. PubMed ID: 25473921
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic lignans from the stem bark of Magnolia officinalis.
Youn UJ; Chen QC; Jin WY; Lee IS; Kim HJ; Lee JP; Chang MJ; Min BS; Bae KH
J Nat Prod; 2007 Oct; 70(10):1687-9. PubMed ID: 17918910
[TBL] [Abstract][Full Text] [Related]
15. Novel 1,3,4-thiadiazole/oxadiazole-linked honokiol derivatives suppress cancer via inducing PI3K/Akt/mTOR-dependent autophagy.
Xu T; Tian W; Zhang Q; Liu J; Liu Z; Jin J; Guo Y; Bai LP
Bioorg Chem; 2021 Oct; 115():105257. PubMed ID: 34426156
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and microbiological evaluation of honokiol derivatives as new antimicrobial agents.
Kim YS; Lee JY; Park J; Hwang W; Lee J; Park D
Arch Pharm Res; 2010 Jan; 33(1):61-5. PubMed ID: 20191344
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of pyrazolignans. A new class of cytotoxic agents.
Gordaliza M; del Corral JM; Castro MA; López-Vázquez ML; San Feliciano A; García-Grávalos MD; Carpy A
Bioorg Med Chem; 1995 Sep; 3(9):1203-10. PubMed ID: 8564411
[TBL] [Abstract][Full Text] [Related]
18. Facile purification of honokiol and its antiviral and cytotoxic properties.
Amblard F; Delinsky D; Arbiser JL; Schinazi RF
J Med Chem; 2006 Jun; 49(11):3426-7. PubMed ID: 16722664
[TBL] [Abstract][Full Text] [Related]
19. A new dimeric neolignan from Magnolia grandiflora L. seeds.
Li HM; Zhao SR; Huo Q; Ma T; Liu H; Lee JK; Hong YS; Wu CZ
Arch Pharm Res; 2015 Jun; 38(6):1066-71. PubMed ID: 25193624
[TBL] [Abstract][Full Text] [Related]
20. The mechanism of honokiol-induced intracellular Ca(2+) rises and apoptosis in human glioblastoma cells.
Liang WZ; Chou CT; Chang HT; Cheng JS; Kuo DH; Ko KC; Chiang NN; Wu RF; Shieh P; Jan CR
Chem Biol Interact; 2014 Sep; 221():13-23. PubMed ID: 25106108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
